Rheumatoid arthritis (RA) is a chronic autoimmune condition. The UM Faculty Physicians team is dedicated to helping you ...

A new approach targets the B-cell pathway with bispecific antibodies, building on decades of research that establishes the ...

New data reinforce rosnilimab’s efficacy profile in rheumatoid arthritis (RA) with deepening of clinical responses, including CDAI remission, ...

The new biotech Elevara plans to initiate Phase II testing of its lead candidate ELV001 as an add-on treatment for rheumatoid ...

A research team has announced the results of a study on osteoblasts that damage joint bones in patients with rheumatoid arthritis. A research team, led by Professor Sung Ho Park in the Department of ...

Q: I’ve had rheumatoid arthritis for 12 years. I’m currently using methotrexate and Humira, but do you think there’s any hope for a cure? A: There no cure as yet, but there’s a lot of research into ...

A machine learning model can use patient-reported data and remote therapeutic monitoring to accurately assess low disease ...

Rheumatoid arthritis (RA) may cause inflammation in your eyes, leading to complications such as dry eyes, redness, and floaters, among others. Early treatment may prevent these conditions from ...

Peripheral neuropathy can develop as a complication of rheumatoid arthritis (RA). You may find similar treatments for both, but your doctor is best equipped to determine what medications may work for ...

CHICAGO -- Hitting rheumatoid arthritis (RA) early and hard, with targeted therapies as first-line treatment, appears to ...

More than 30% of patients with rheumatic disease, and more than 40% of those with rheumatoid arthritis, experienced flares ...